AC
AUPH icon

AXQ Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

AXQ Capital’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240K Sell
14,127
-4,948
-26% -$79K 0.03% 672
2026
Q1 		$283K Sell
19,075
-1,562
-8% -$22.8K 0.04% 621
2025
Q4 		$329K Sell
20,637
-375
-2% -$5.32K 0.07% 409
2025
Q3 		$232K Buy
+21,012
New +$229K 0.09% 406
2023
Q3 		– Sell
-19,100
Closed -$185K – 465
2023
Q2 		$185K Buy
+19,100
New +$198K 0.23% 213

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AXQ Capital's AUPH Position: Q2 2026 in Review

AXQ Capital reduced its Aurinia Pharmaceuticals (AUPH) stake by 26% in Q2 2026, selling an estimated $79K and leaving 14,127 shares worth $240K. The position accounts for 0.03% of the portfolio, ranked #672.

AXQ Capital first reported a position in AUPH in Q2 2023 and has held it in 5 quarters since. The position peaked at $329K in Q4 2025. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • AXQ Capital held 14,127 shares of Aurinia Pharmaceuticals worth $240K as of Q2 2026.
  • AXQ Capital sold 4,948 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $79K.
  • Aurinia Pharmaceuticals made up 0.03% of AXQ Capital's portfolio in Q2 2026, its #672 holding.
  • AXQ Capital first reported a position in Aurinia Pharmaceuticals in Q2 2023 and has held it in 5 quarters since.
  • AXQ Capital's Aurinia Pharmaceuticals position peaked at $329K in Q4 2025.
  • 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.